A medical cannabis clinic is a healthcare provider that assesses patients, arranges specialist prescribing where clinically appropriate and remains responsible for monitoring. It is not a dispensary or a route to choose a product without assessment. The useful checks are regulation, the initiating specialist, the records pathway, clinical governance, pharmacy arrangements and follow-up.
Key takeaways
- Healthcare regulation differs across England, Scotland, Wales and Northern Ireland.
- For an unlicensed CBPM, the prescription or direction must come from a doctor on the GMC Specialist Register.
- The specialist must work within their own field of competence; appearing on the register is not enough on its own.
- A clinic should review relevant records, previous treatments, current medicines and risk factors before deciding suitability.
- Initial unlicensed prescribing should generally be peer-reviewed through an appropriate MDT or equivalent governance process; the prescriber remains responsible.
- The clinic should explain fees, pharmacy arrangements, side-effect support and review expectations before treatment starts.
How clinics are regulated
The provider’s regulator depends on where and how the service operates. The Care Quality Commission covers relevant providers in England. Healthcare Improvement Scotland regulates independent healthcare services in Scotland, Healthcare Inspectorate Wales regulates independent healthcare in Wales, and the Regulation and Quality Improvement Authority covers regulated services in Northern Ireland.
Check the entry that matches the provider’s legal entity and service, not just a logo in the website footer. Read any inspection report, registration conditions and contact details. A regulator entry checks the provider; the GMC register checks the doctor. You need both parts of the picture.
The GMC says the supply of an unlicensed CBPM must be in accordance with a prescription or direction from a doctor on its Specialist Register. That doctor must prescribe within their competence, support informed decision-making and consider authoritative guidance. Initial prescribing should generally be peer-reviewed through an appropriate MDT or equivalent, proportionate governance process. Other authorised prescribers may sometimes continue treatment under specialist direction; licensed medicines follow their own prescribing rules.
What a clinic assessment should cover
The practical route normally begins with records. Ask what relevant medical-record information the clinic needs. In England, a Summary Care Record may help, but fuller GP records or specialist letters may be needed if it does not show enough diagnosis and treatment history. This is normally an administrative records step, not a request for GP approval.
The specialist should consider the patient’s symptoms, previous treatments, current medicines and supplements, mental-health history, substance-use concerns, previous cannabis reactions and relevant physical-health risks. Pregnancy, breastfeeding, driving, work and caring responsibilities may also matter. The purpose is to decide whether a cannabis-based medicine is appropriate and how it could be monitored, not to reward a patient for saying the right thing.
Patients can discuss whether they hoped to ask about flower, oil, an extract or another form. They can raise practical preferences and concerns. The prescriber remains responsible for deciding whether any product form, route or dose is suitable.
For the sequence from first steer to pharmacy dispensing, read what makes a UK cannabis prescription valid and what happens at a clinic consultation.
What to check before paying
Ask for a written fee schedule covering the first assessment, required reviews, repeat-prescription administration, letters, delivery and any membership term. Ask which pharmacy receives prescriptions, whether another pharmacy can be requested, how stock changes are handled and who answers clinical questions between reviews.
Also ask how the clinic handles side effects, urgent concerns, complaints, switching providers and discharge. There is no universal appointment length or follow-up interval that proves quality; the clinic should explain why its process is appropriate and who remains clinically responsible.
Use the clinic comparison framework for a structured shortlist. If a provider advertises a reduced-fee route, read the access-scheme guide and check the current terms.
Pause if a provider implies that a prescription is decided before records and specialist assessment, will not identify the responsible specialist, cannot point you to the relevant regulator entry, hides continuing fees or markets an unlicensed medicine as risk-free. Speak to the clinic about clinical concerns and to the relevant regulator if you cannot verify registration or need to raise a care-quality concern.
Read next
- How to compare medical cannabis clinics without rankings
- What happens at a UK cannabis clinic consultation
- What makes a UK cannabis prescription valid
- Clinic fees to ask about before signing up
Source trail
- GMC: Information for doctors on cannabis-based products for medicinal use
- GMC: The medical register
- NHS England: Cannabis-based products for medicinal use
- CQC: Find regulated care services in England
- Healthcare Inspectorate Wales
- Healthcare Improvement Scotland: independent healthcare registration
- Regulation and Quality Improvement Authority, Northern Ireland
